View in EDS PDF Full Text

Study Design and Baseline Characteristics of the CARDINAL Trial: A Phase 3 Study of Bardoxolone Methyl in Patients with Alport Syndrome.

Saved in:
Bibliographic Details
Title: Study Design and Baseline Characteristics of the CARDINAL Trial: A Phase 3 Study of Bardoxolone Methyl in Patients with Alport Syndrome.
Authors: Chertow GM; Division of Nephrology, Department of Medicine, Stanford University School of Medicine, Palo Alto, California, USA., Appel GB; Division of Nephrology, Department of Medicine, Columbia University College of Physicians and Surgeons, New York, New York, USA., Andreoli S; Riley Hospital for Children, Indiana University School of Medicine, Indianapolis, Indiana, USA., Bangalore S; Cardiovascular Clinical Research Center, New York University School of Medicine, New York, New York, USA., Block GA; Department of Clinical Research and Medical Affairs, US Renal Care, Inc., Plano, Texas, USA., Chapman AB; Section of Nephrology, University of Chicago, Chicago, Illinois, USA., Chin MP; Department of Product Development, Reata Pharmaceuticals, Plano, Texas, USA., Gibson KL; University of North Carolina Kidney Center at Chapel Hill, Chapel Hill, North Carolina, USA., Goldsberry A; Department of Product Development, Reata Pharmaceuticals, Plano, Texas, USA., Iijima K; Department of Pediatrics, Kobe University Graduate School of Medicine, Kobe, Japan., Inker LA; Division of Nephrology, Tufts Medical Center, Boston, Massachusetts, USA., Knebelmann B; Department of Nephrology, Necker Hospital, AP-HP, Université de Paris, Paris, France., Mariani LH; Department of Internal Medicine, Division of Nephrology, University of Michigan, Ann Arbor, Michigan, USA., Meyer CJ; Department of Product Development, Reata Pharmaceuticals, Plano, Texas, USA., Nozu K; Department of Pediatrics, Kobe University Graduate School of Medicine, Kobe, Japan., O'Grady M; Department of Product Development, Reata Pharmaceuticals, Plano, Texas, USA., Silva AL; Boise Kidney and Hypertension Institute, Meridian, Idaho, USA., Stenvinkel P; Division of Renal Medicine and Baxter Novum, Department of Clinical Science, Technology and Intervention, Karolinska Institutet, Stockholm, Sweden., Torra R; Inherited Kidney Disorders, Nephrology Department, Fundacio Puigvert, Instituto de Investigacion Carlos III, Universitat Autonoma de Barcelona, Barcelona, Spain., Warady BA; Division of Pediatric Nephrology, Children's Mercy Kansas City, Kansas City, Missouri, USA., Pergola PE; Renal Associates PA, San Antonio, Texas, USA.
Source: American journal of nephrology [Am J Nephrol] 2021; Vol. 52 (3), pp. 180-189. Date of Electronic Publication: 2021 Mar 31.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Clinical Trial Protocol
Journal Info: Publisher: Karger Country of Publication: Switzerland NLM ID: 8109361 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1421-9670 (Electronic) Linking ISSN: 02508095 NLM ISO Abbreviation: Am J Nephrol Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 33789284
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Study Design and Baseline Characteristics of the CARDINAL Trial: A Phase 3 Study of Bardoxolone Methyl in Patients with Alport Syndrome.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Chertow+GM%22">Chertow GM</searchLink>; Division of Nephrology, Department of Medicine, Stanford University School of Medicine, Palo Alto, California, USA.<br /><searchLink fieldCode="AU" term="%22Appel+GB%22">Appel GB</searchLink>; Division of Nephrology, Department of Medicine, Columbia University College of Physicians and Surgeons, New York, New York, USA.<br /><searchLink fieldCode="AU" term="%22Andreoli+S%22">Andreoli S</searchLink>; Riley Hospital for Children, Indiana University School of Medicine, Indianapolis, Indiana, USA.<br /><searchLink fieldCode="AU" term="%22Bangalore+S%22">Bangalore S</searchLink>; Cardiovascular Clinical Research Center, New York University School of Medicine, New York, New York, USA.<br /><searchLink fieldCode="AU" term="%22Block+GA%22">Block GA</searchLink>; Department of Clinical Research and Medical Affairs, US Renal Care, Inc., Plano, Texas, USA.<br /><searchLink fieldCode="AU" term="%22Chapman+AB%22">Chapman AB</searchLink>; Section of Nephrology, University of Chicago, Chicago, Illinois, USA.<br /><searchLink fieldCode="AU" term="%22Chin+MP%22">Chin MP</searchLink>; Department of Product Development, Reata Pharmaceuticals, Plano, Texas, USA.<br /><searchLink fieldCode="AU" term="%22Gibson+KL%22">Gibson KL</searchLink>; University of North Carolina Kidney Center at Chapel Hill, Chapel Hill, North Carolina, USA.<br /><searchLink fieldCode="AU" term="%22Goldsberry+A%22">Goldsberry A</searchLink>; Department of Product Development, Reata Pharmaceuticals, Plano, Texas, USA.<br /><searchLink fieldCode="AU" term="%22Iijima+K%22">Iijima K</searchLink>; Department of Pediatrics, Kobe University Graduate School of Medicine, Kobe, Japan.<br /><searchLink fieldCode="AU" term="%22Inker+LA%22">Inker LA</searchLink>; Division of Nephrology, Tufts Medical Center, Boston, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Knebelmann+B%22">Knebelmann B</searchLink>; Department of Nephrology, Necker Hospital, AP-HP, Université de Paris, Paris, France.<br /><searchLink fieldCode="AU" term="%22Mariani+LH%22">Mariani LH</searchLink>; Department of Internal Medicine, Division of Nephrology, University of Michigan, Ann Arbor, Michigan, USA.<br /><searchLink fieldCode="AU" term="%22Meyer+CJ%22">Meyer CJ</searchLink>; Department of Product Development, Reata Pharmaceuticals, Plano, Texas, USA.<br /><searchLink fieldCode="AU" term="%22Nozu+K%22">Nozu K</searchLink>; Department of Pediatrics, Kobe University Graduate School of Medicine, Kobe, Japan.<br /><searchLink fieldCode="AU" term="%22O'Grady+M%22">O'Grady M</searchLink>; Department of Product Development, Reata Pharmaceuticals, Plano, Texas, USA.<br /><searchLink fieldCode="AU" term="%22Silva+AL%22">Silva AL</searchLink>; Boise Kidney and Hypertension Institute, Meridian, Idaho, USA.<br /><searchLink fieldCode="AU" term="%22Stenvinkel+P%22">Stenvinkel P</searchLink>; Division of Renal Medicine and Baxter Novum, Department of Clinical Science, Technology and Intervention, Karolinska Institutet, Stockholm, Sweden.<br /><searchLink fieldCode="AU" term="%22Torra+R%22">Torra R</searchLink>; Inherited Kidney Disorders, Nephrology Department, Fundacio Puigvert, Instituto de Investigacion Carlos III, Universitat Autonoma de Barcelona, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Warady+BA%22">Warady BA</searchLink>; Division of Pediatric Nephrology, Children's Mercy Kansas City, Kansas City, Missouri, USA.<br /><searchLink fieldCode="AU" term="%22Pergola+PE%22">Pergola PE</searchLink>; Renal Associates PA, San Antonio, Texas, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%228109361%22">American journal of nephrology</searchLink> [Am J Nephrol] 2021; Vol. 52 (3), pp. 180-189. <i>Date of Electronic Publication: </i>2021 Mar 31.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, Non-U.S. Gov't; Clinical Trial Protocol
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Karger%22">Karger </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>8109361 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1421-9670 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2202508095%22">02508095 </searchLink><i>NLM ISO Abbreviation: </i>Am J Nephrol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=33789284
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1159/000513777
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 180
    Titles:
      – TitleFull: Study Design and Baseline Characteristics of the CARDINAL Trial: A Phase 3 Study of Bardoxolone Methyl in Patients with Alport Syndrome.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Chertow GM
      – PersonEntity:
          Name:
            NameFull: Appel GB
      – PersonEntity:
          Name:
            NameFull: Andreoli S
      – PersonEntity:
          Name:
            NameFull: Bangalore S
      – PersonEntity:
          Name:
            NameFull: Block GA
      – PersonEntity:
          Name:
            NameFull: Chapman AB
      – PersonEntity:
          Name:
            NameFull: Chin MP
      – PersonEntity:
          Name:
            NameFull: Gibson KL
      – PersonEntity:
          Name:
            NameFull: Goldsberry A
      – PersonEntity:
          Name:
            NameFull: Iijima K
      – PersonEntity:
          Name:
            NameFull: Inker LA
      – PersonEntity:
          Name:
            NameFull: Knebelmann B
      – PersonEntity:
          Name:
            NameFull: Mariani LH
      – PersonEntity:
          Name:
            NameFull: Meyer CJ
      – PersonEntity:
          Name:
            NameFull: Nozu K
      – PersonEntity:
          Name:
            NameFull: O'Grady M
      – PersonEntity:
          Name:
            NameFull: Silva AL
      – PersonEntity:
          Name:
            NameFull: Stenvinkel P
      – PersonEntity:
          Name:
            NameFull: Torra R
      – PersonEntity:
          Name:
            NameFull: Warady BA
      – PersonEntity:
          Name:
            NameFull: Pergola PE
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 01
              Text: 2021
              Type: published
              Y: 2021
          Identifiers:
            – Type: issn-electronic
              Value: 1421-9670
          Numbering:
            – Type: volume
              Value: 52
            – Type: issue
              Value: 3
          Titles:
            – TitleFull: American journal of nephrology
              Type: main
ResultId 1